All Pharma News
price-trendAsk Us
Merck & Co. opts in on Orion`s hormone-dependent cancer candidates

Merck & Co. opts in on Orion`s hormone-dependent cancer candidates
FIERCE BIOTECH
01 Jul 2024
Share Share
Proteros and Orion Pharma agree on a long-term multi-target collaboration

Proteros and Orion Pharma agree on a long-term multi-target collaboration
GLOBENEWSWIRE
06 Sep 2023
Share Share
Orion Group Financial Statement documents 2022

Orion Group Financial Statement documents 2022
GLOBENEWSWIRE
28 Feb 2023
Share Share
Orion’s collaboration partner Bayer submits application for of darolutamide

Orion’s collaboration partner Bayer submits application for of darolutamide
GLOBENEWSWIRE
21 Apr 2022
Share Share
ARASENS Phase III trial for prostate cancer treatment meets primary endpoint

ARASENS Phase III trial for prostate cancer treatment meets primary endpoint
PHARMAFILE
03 Dec 2021
Share Share